Specify a stock or a cryptocurrency in the search bar to get a summary
Amplitude Surgical SAS
AMPLIAmplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. As of January 21, 2021, Amplitude Surgical SA operates as a subsidiary of PAI Partners. Address: 11, Cours Jacques Offenbach, Valence, France, 26000
Analytics
WallStreet Target Price
4.04 EURP/E ratio
104.6667Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures AMPLI
Dividend Analytics AMPLI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History AMPLI
Stock Valuation AMPLI
Financials AMPLI
Results | 2019 | Dynamics |